Navigation Links
New Jersey Plastic Surgeon Helps Determine Top Cosmetic Surgery Procedures of 2008
Date:3/18/2009

growth and sustainability of our industry," says New Jersey plastic surgeon, Dr. Parker. "I was glad to release my practice information to help ASAPS gather the data they needed to support our industry."

The study also determined that women had 92 percent of all cosmetic procedures last year totaling 9.3 million with men undergoing 800,000 procedures at 8 percent.

Parker Center for Plastic Surgery attempts to respond within 24 hours to all press inquiries and will happily make Dr. Parker available on request.

For further information on New Jersey Plastic Surgeon, Dr. Paul Parker, visit www.parkercenter.net.

Dr. Paul M. Parker is a graduate of George Washington University of Medicine in Washington, DC, where he was the recipient of the distinguished CV Mosby Award of Excellence.

He completed residencies in both General Surgery and Plastic Surgery at New York University Medical Center, where he received the Theodore Barnett Award for Excellence in Teaching. He also completed a fellowship in Microsurgery at New York University Medical Center's Institute of Reconstructive Plastic Surgery with heavy emphasis on innovative methods of breast surgery and breast reconstruction.

Dr. Parker is certified by the American Board of Plastic Surgery and is a Fellow of the American College of Surgeons and an active member of the American Society of Plastic Surgeons, the American Society for Aesthetic Plastic Surgery, the Northeastern Society of Plastic Surgeons, the American Society for Laser Medicine and Surgery, and the New Jersey Society of Plastic Surgeons.


'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. First Rewards Paid to New Jersey Doctors Through Participation in Bridges to Excellence
2. $12 Million New Jersey Medical Malpractice Verdict for Wrongful Death of a 21-Year-Old Man After Having Wisdom Teeth Removed
3. Hackensack Lawyer Bruce E. Chase Named New Jersey Super Lawyer for Third Consecutive Year
4. New Jersey to Launch New Statewide Effort to Promote Childhood Obesity Prevention
5. Cultural Competency Training to Meet State Requirements for New Jersey Physicians
6. Turner Reaches Milestone on $323 Million Virtua West Jersey Replacement Hospital in Voorhees, N.J.
7. CASA* Evaluation of Welfare Demonstration Program in New Jersey Finds Effective Approach to Addiction Recovery and Employment
8. MinuteClinic Becomes Participating Provider With Horizon Blue Cross Blue Shield of New Jersey
9. Interested in Breast Augmentation, New Jersey? Be Sure You Know the “Real Cost”
10. Stuart M. Goldstein, Southern New Jersey Patent and Intellectual Property Attorney, secures a New Revolutionary Eco-Friendly Patent
11. New Jersey-Based Biotech Start-Up Nexomics Biosciences Gets Off the Ground
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Jersey Plastic Surgeon Helps Determine Top Cosmetic Surgery Procedures of 2008
(Date:1/22/2015)... Oceanside,CA (PRWEB) January 22, 2015 For over 20 ... the Oceanside and Vista area has treated just about ... other personal injury circumstances. And for those same twenty-plus years, ... victims of all those injuries with the best possible doctor. ...
(Date:1/22/2015)... Yesterday, Senator Holly Mitchell (D-Los ... Olsen (R-Modesto) were honored by the California Healthcare ... biomedical science, medical device and pharmaceutical innovation in ... “2014 Life Sciences Champion” award from CHI President ...
(Date:1/22/2015)... 22, 2015 Payday lending practices in ... and cause financial distress to the states that permit ... Howard University’s Center on Race and Wealth. , While ... activity, payday loans at the same time substantially depress ...
(Date:1/22/2015)... 22, 2015 Compare-autoinsurance.org has released a new blog ... an auto insurance policy . , Some types of ... should check the newly released blog post to see if their ... dangerously damaged vehicles are some of the cars that cannot be ...
(Date:12/26/2014)... The US represents the largest market for ... GlobalData’s forecast estimates that sales of branded therapies were $2.23 ... the high incidence of the disease, high drug treatment rate, ... China. Increased sales of CRC therapies over the forecast period ...
Breaking Medicine News(10 mins):Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:Some Vehicles Cannot Be Covered By An Auto Insurance Policy! 2Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 2Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 3Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 4
... http://www.nhs.uk ), the,digital ,front door, to the NHS launches ... both the physical and financial cost of smoking in ... interactive calculator,( http://www.nhs.uk/Tools/Pages/Smoking.aspx ) enables users to not only ... much you could save over,one to ten years - ...
... 11 In this 90 minute episode, Dr. Drew,reunites several ... they left treatment. Drew reveals who has relapsed, who has ... is comprised of,recovering addicts and fans of the show, will ... happened over the season., (Photos: ...
... as whole grains cuts risk of cerebral infarction , , ... magnesium-rich foods such as whole grains may reduce male ... flow to the brain is blocked, a new Swedish ... Stockholm analyzed the diets and other health/lifestyle habits and ...
... March 11 Perrigo Company,(Nasdaq: PRGO ; TASE) ... U.S. Food and Drug Administration (FDA) for its Abbreviated ... The product is a topical corticosteroid indicated for the ... for the brand, Olux(R),Foam, 0.05%, were approximately $85 million ...
... 11 Verathon(R) is pleased to,announce a new ... 9400,bladder volume instrument with patent-pending NeuralHarmonics(TM),Technology. Small Child ... noninvasively on children weighing less than 60 pounds ... same instrument used for adult,patients. This enhanced BladderScan(R) ...
... German . , Malignant tumors have usually ... death, or apoptosis. Therefore, tumors are often resistant to ... forcing tumor cells to commit suicide. , This ... of the numerous molecular switches regulating the self-destruction process. ...
Cached Medicine News:Health News:Magnesium May Lower Risk for Some Strokes in Male Smokers 2Health News:Perrigo Company Receives Final Approval on Clobetasol Propionate Foam 2Health News:Perrigo Company Receives Final Approval on Clobetasol Propionate Foam 3Health News:Verathon Inc. Launches Enhanced BladderScan(R) Bladder Volume Instrument With Small Child Mode 2Health News:Verathon Inc. Launches Enhanced BladderScan(R) Bladder Volume Instrument With Small Child Mode 3Health News:Paradigm shift: Switch for programmed cell death promotes spread of glioblastoma 2
(Date:1/23/2015)... Inc. (NASDAQ: NWBO )("NW Bio"), a U.S. biotechnology ... solid tumor cancers, announced today that CEO Linda Powers ... Immunotherapy Forum in Washington D.C. ... January 26 at 10:30 a.m. EST at the Grand Hyatt ...
(Date:1/23/2015)... and DUBLIN , Jan. 23, ... agreement with KRS Global Biotechnology, Inc. for the compounding, packaging ... compounded for shipment in the United States ... approved Outsourcing Facility capable of compounding naltrexone tablets in various ...
(Date:1/23/2015)... , Jan. 23, 2015  HyGreen, Inc., a leader ... and partnership with RCA Medical, a subsidiary of Ascendis ... . Each year, hundreds of millions of ... infections as organisms are transmitted from patient to patient ...
Breaking Medicine Technology:NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 2NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 3Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 2Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 3Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 4HyGreen Partners with RCA Medical in Johannesburg, South Africa 2
... 2007 /PRNewswire/ -- Once-daily,dosing with Otsuka's investigational ... associated with improvements,in signs and symptoms of ... receiving conventional care, without an,adverse effect on ... from the short- and long-term analyses of ...
... Stent Technology Holds Promise as,Future-Generation Treatment Option ... ABBOTT PARK, Ill., March 24, 2007 /PRNewswire-FirstCall/ ... the world's,first clinical trial evaluating the overall ... eluting stent platform for the,treatment of coronary ...
Cached Medicine Technology:Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 2Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 3Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 4Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 5Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 6Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 7Abbott Announces Positive Six-Month Results From the World's First,Clinical Trial of a Fully Bioabsorbable Drug-Eluting Coronary Stent 2Abbott Announces Positive Six-Month Results From the World's First,Clinical Trial of a Fully Bioabsorbable Drug-Eluting Coronary Stent 3
Series I Small Joint Arthroscopy Hand Instruments feature small yet durable instruments specifically designed for small joint arthroscopy. They are available in a variety of low profile styles: strai...
Low-profile, hand-held instrument....
Low-profile, hand-held instrument....
Developed in conjunction with Pierce E. Scranton, Jr., M.D., the Seattle Small Joint Arthroscopy Set offers meticulously designed instrumentation for elbow, foot, and ankle surgeries....
Medicine Products: